Group A Streptococcus encounters with host macrophages
- PMID: 29226710
- PMCID: PMC5771463
- DOI: 10.2217/fmb-2017-0142
Group A Streptococcus encounters with host macrophages
Abstract
Group A Streptococcus (GAS) is a leading human bacterial pathogen with diverse clinical manifestations. Macrophages constitute a critical first line of host defense against GAS infection, using numerous surface and intracellular receptors such as Toll-like receptors and inflammasomes for pathogen recognition and activation of inflammatory signaling pathways. Depending on the intensity of the GAS infection, activation of these signaling cascades may provide a beneficial early alarm for effective immune clearance, or conversely, may cause hyperinflammation and tissue injury during severe invasive infection. Although traditionally considered an extracellular pathogen, GAS can invade and replicate within macrophages using specific molecular mechanisms to resist phagolysosomal and xenophagic killing. Unraveling GAS-macrophage encounters may reveal new treatment options for this leading agent of infection-associated mortality. [Formula: see text].
Keywords: Group A Streptococcus (GAS); IL-1β signaling; NLRP3 inflammasome; Toll-like receptors; intracellular survival; macrophage; phagocytosis; xenophagy.
Conflict of interest statement
This work was supported by National Institutes of Health grants number AI077780 and AI096837. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.
Figures



Similar articles
-
A group A Streptococcus ADP-ribosyltransferase toxin stimulates a protective interleukin 1β-dependent macrophage immune response.mBio. 2015 Mar 10;6(2):e00133. doi: 10.1128/mBio.00133-15. mBio. 2015. PMID: 25759502 Free PMC article.
-
Group A streptococcal M protein activates the NLRP3 inflammasome.Nat Microbiol. 2017 Oct;2(10):1425-1434. doi: 10.1038/s41564-017-0005-6. Epub 2017 Aug 7. Nat Microbiol. 2017. PMID: 28784982 Free PMC article.
-
Streptolysin O and NAD-glycohydrolase prevent phagolysosome acidification and promote group A Streptococcus survival in macrophages.mBio. 2014 Sep 16;5(5):e01690-14. doi: 10.1128/mBio.01690-14. mBio. 2014. PMID: 25227466 Free PMC article.
-
How group A Streptococcus circumvents host phagocyte defenses.Future Microbiol. 2007 Feb;2(1):75-84. doi: 10.2217/17460913.2.1.75. Future Microbiol. 2007. PMID: 17661677 Review.
-
Responses of innate immune cells to group A Streptococcus.Front Cell Infect Microbiol. 2014 Oct 2;4:140. doi: 10.3389/fcimb.2014.00140. eCollection 2014. Front Cell Infect Microbiol. 2014. PMID: 25325020 Free PMC article. Review.
Cited by
-
Streptococcal peptides and their roles in host-microbe interactions.Front Cell Infect Microbiol. 2023 Oct 16;13:1282622. doi: 10.3389/fcimb.2023.1282622. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37915845 Free PMC article. Review.
-
Recognition of Lipoproteins by Toll-like Receptor 2 and DNA by the AIM2 Inflammasome Is Responsible for Production of Interleukin-1β by Virulent Suilysin-negative Streptococcus suis Serotype 2.Pathogens. 2020 Feb 21;9(2):147. doi: 10.3390/pathogens9020147. Pathogens. 2020. PMID: 32098284 Free PMC article.
-
Streptococcus pyogenes infects human endometrium by limiting the innate immune response.J Clin Invest. 2021 Feb 15;131(4):e130746. doi: 10.1172/JCI130746. J Clin Invest. 2021. PMID: 33320843 Free PMC article.
-
[Research progress on the mechanism of -lactam resistance in group A Streptococci in vivo].Zhongguo Dang Dai Er Ke Za Zhi. 2024 Jan 15;26(1):92-97. doi: 10.7499/j.issn.1008-8830.2306157. Zhongguo Dang Dai Er Ke Za Zhi. 2024. PMID: 38269466 Free PMC article. Review. Chinese.
-
C4b-Binding Protein and Factor H Attenuate NLRP3 Inflammasome-Mediated Signalling Response during Group A Streptococci Infection in Human Cells.J Innate Immun. 2024;16(1):554-572. doi: 10.1159/000542434. Epub 2024 Nov 4. J Innate Immun. 2024. PMID: 39496236 Free PMC article.
References
-
- Ralph AP, Carapetis JR. Group A streptococcal diseases and their global burden. Curr. Top. Microbiol. Immunol. 2013;368:1–27. - PubMed
-
- Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 2005;5:685–694. - PubMed
-
- Cole JN, Barnett TC, Nizet V, Walker MJ. Molecular insight into invasive group A streptococcal disease. Nat. Rev. Microbiol. 2011;9:724–736. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical